Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | $54.40M | $57.76M | 32.47% | +$3.35M |
| Centessa Pharmaceuticals IncADS | 1,253,379 | 1,253,379 | 0 | $18.02M | $16.47M | 9.26% | -$1.55M |
| Akero Therapeutics Inc | 365,000 | 244,900 | -120,100 | $14.78M | $13.07M | 7.35% | -$1.71M |
| Alumis Inc | 4,202,670 | 4,247,670 | +45,000 | $25.80M | $12.74M | 7.16% | -$13.06M |
| Rapt Therapeutics Inc | 0 | 1,562,500 | +1,562,500 | $0 | $12.50M | 7.03% | +$12.50M |
| Bicara Therapeutics Inc | 950,000 | 949,260 | -740 | $12.38M | $8.82M | 4.96% | -$3.56M |
| Edgewise Therapeutics, Inc.(EWTX) | 585,000 | 585,000 | 0 | $12.87M | $7.67M | 4.31% | -$5.20M |
| Hinge Health, Inc.CL A(HNGE) | 0 | 135,000 | +135,000 | $0 | $6.99M | 3.93% | +$6.99M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,581,233 | 1,731,233 | +150,000 | $5.03M | $6.92M | 3.89% | +$1.90M |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | $4.01M | $6.39M | 3.59% | +$2.38M |
| Verastem, Inc.(VSTM) | 0 | 1,276,520 | +1,276,520 | $0 | $5.30M | 2.98% | +$5.30M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 160,000 | +160,000 | $0 | $5.01M | 2.82% | +$5.01M |
| Cullinan Therapeutics, Inc.(CGEM) | 634,558 | 594,025 | -40,533 | $4.80M | $4.47M | 2.51% | -$330.6K |
| Structure Therapeutics IncADS | 420,000 | 210,000 | -210,000 | $7.27M | $4.36M | 2.45% | -$2.91M |
| Allogene Therapeutics Inc | 3,448,275 | 2,875,357 | -572,918 | $5.03M | $3.25M | 1.83% | -$1.79M |
| IDEAYA Biosciences, Inc.(IDYA) | 0 | 144,468 | +144,468 | $0 | $3.04M | 1.71% | +$3.04M |
| Avidity Biosciences Inc | 0 | 40,000 | +40,000 | $0 | $1.14M | 0.64% | +$1.14M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 70,000 | +70,000 | $0 | $1.05M | 0.59% | +$1.05M |
| CASI Pharmaceuticals, Inc.(CASIF) | 1,329,383 | 787,121 | -542,262 | $2.87M | $928.8K | 0.52% | -$1.94M |
| Viridian Therapeutics, Inc.(VRDN) | 1,974 | 1,974 | 0 | $26.6K | $27.6K | 0.02% | +$987 |
| Rapt Therapeutics Inc | 12,500,000 | 0 | -12,500,000 | $15.25M | $0 | — | -$15.25M |